
Currently out of the existing stock ratings of David Lebowitz, 196 are a BUY (60.49%), 92 are a HOLD (28.4%), 36 are a SELL (11.11%).
Analyst David Lebowitz, currently employed at BMO, has had 70.98% of price targets met with an average potential upside of 34.6%, reached in 264 days on average. Previously, David Lebowitz worked at CITI.
David Lebowitz has documented 625 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, .
Analyst best performing recommendations are on PLRX.
The best stock recommendation documented was for PLRX on 3/4/2025. The price target of $1.5 was fulfilled within 1 day with a profit of $0.15 (11.11%), with a performance score of 111.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Sep-2023
$4.5
$3.47 (336.89%)
$7.5
2 months 14 days ago
(07-Sep-2026)
15/36 (41.67%)
$3.47 (336.89%)
342
Buy Since 03-Jun-2025
$6
$4.97 (482.52%)
$6
4 months 21 days ago
(30-Jun-2026)
0/5 (0%)
$4.79 (395.87%)
Buy Since 28-Nov-2023
$4
$2.97 (288.35%)
$4
7 months 15 days ago
(06-Apr-2026)
3/7 (42.86%)
$2.62 (189.86%)
578
Buy Since 29-Mar-2022
$4
$2.97 (288.35%)
$2
9 months 16 days ago
(05-Feb-2026)
1/2 (50%)
$2.61 (187.77%)
722
Hold Since 31-May-2023
$4
3 years 5 months 22 days ago
(31-May-2023)
1/12 (8.33%)
$2.96 (284.62%)
784
Stocks David Lebowitz covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.